Idea principal
Among 4500 adults aged 50 or older in western China, 19.31% had sarcopenia, and sarcopenia was linked to mild (odds ratio 1.41) and moderate/severe (OR 3.05) cognitive impairment. It is a single snapshot, so it cannot show which came first.
Study design
Artículo de investigación
Reading basis
Published abstract
Reading focus
Design & applicability
Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.
Pregunta de investigación
Sarcopenia, the loss of muscle mass, strength and function with ageing, is linked to poor health and early death, but its prevalence in China was unclear because studies used different standards. The authors measured how common it is among multi-ethnic adults in western China and whether it goes with cognitive impairment.
Población y método
Community-based analysis of 4500 eligible participants aged 50 or older (mean age 62.4 years, SD 8.3) from the West-China Health and Aging Trend study. Gait speed, handgrip strength and muscle mass (by bioelectrical impedance analysis, BIA) were measured, and sarcopenia was defined with the Asian Working Group for Sarcopenia (AWGS) algorithm. Cognition was assessed with the 10-item Short Portable Mental Status Questionnaire (SPMSQ). Univariate and multivariate analyses adjusted for age, gender, ethnicity and other potential confounders.
Resultados
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Sarcopenia was present in 869 of 4500 participants (19.31%). Mild cognitive impairment was found in 446 (9.9%) and moderate/severe impairment in 144 (3.2%).
- 2After adjustment, cognitive impairment was independently associated with sarcopenia, with a dose pattern: odds ratio 1.41 (95% CI 1.10-1.82) for mild and 3.05 (95% CI 2.08-4.49) for moderate/severe impairment.
- 3By gender, the mild-impairment link was not significant in men but remained significant in women. The moderate/severe link was significant in both men and women.
Límites e incertidumbre
- 1Cross-sectional design: it shows an association at one point in time and cannot say whether weak muscles contribute to cognitive decline, the reverse, or neither.
- 2Muscle mass was estimated with BIA and cognition with a brief 10-item questionnaire, both rougher than imaging or full neuropsychological testing.
- 3The abstract does not give ethnic-group results or exact adjusted variables, and the sex-specific findings are subgroup analyses. This reading is based on the abstract only.
Relevancia práctica
Muscle loss and thinking problems often appear together in older adults, so a decline in grip strength or walking speed is worth mentioning to a clinician. These data cannot show that building muscle protects cognition. Questions about diagnosis or treatment belong with a clinician.
Tus datos
Gait speed and handgrip strength are the kind of measures used here; walking pace over a fixed route or a hand dynamometer can be repeated under the same conditions. Home body-composition scales use impedance too, but their muscle estimates vary by device, so compare trends on one device only.
Cómo interpretar la evidencia
The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.
Resumen estructurado de los autores English
El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.
Background
Sarcopenia is a condition that is characterized by loss of muscle mass, muscle strength and muscle functional impairment with ageing. It is associated with poor health outcomes, premature death and a significant burden on the global health economy. The prevalence of sarcopenia in China is unknown since most of the studies are lack of uniform standard. The study was undertaken to study the prevalence of sarcopenia and the association with cognitive impairment among multi-ethnic adults aged 50 years old or older in western China.
Methods
We measured gait speed, handgrip strength and muscle mass by using bioelectrical impedance analysis (BIA) for all eligible participants and 4500 participants were eligible for the analysis. We defined sarcopenia using the diagnostic algorithm recommended by the Asian Working Group for Sarcopenia (AWGS). We assessed the participants' cognitive functions using the 10-item Short Portable Mental Status Questionnaire (SPMSQ). Relationships between sarcopenia and cognitive impairment were analyzed using univariate and multivariate analyses.
Results
Of 4500 participants (mean age 62.4 ± 8.3 years), 869 (19.31%) adults were sarcopenia. 446 (9.9%) participants were identified as having mild cognitive impairment, 144 (3.2%) adults were identified as having moderate/severe cognitive impairment. After adjusting for age, gender, ethnics and other potential cofounders, cognitive impairment was found to be independently associated with sarcopenia with a dosage effect (mild cognitive impairment: odds ratio [OR]: 1.41, 95% CI 1.10-1.82; moderate/severe cognitive impairment: OR: 3.05, 95% CI 2.08-4.49). After gender stratification, the association between mild cognitive impairment with sarcopenia in male is not significant, while is still significant in female. While the association between moderate/severe cognitive impairment is independently associated with sarcopenia in both male and female.
Conclusions
The prevalence rates of sarcopenia, mild cognitive impairment, moderate/severe cognitive impairment among the communities aged 50 or older in western China were 19.31, 9.9 and 3.2%, respectively. Cognitive impairment was significantly associated with sarcopenia with a dosage effect, especially in female.
Fuentes y atribución
Prevalence of sarcopenia in multi ethnics adults and the association with cognitive impairment: findings from West-China health and aging trend study.
Liu X, Hou L, Xia X, Liu Y, Zuo Z, Zhang Y, Zhao W, Hao Q, Yue J, Dong B.
BMC geriatrics · 2020-02-17
DOI: 10.1186/s12877-020-1468-5 ↗PubMed · 32066390 ↗Europe PMC · Licencia registrada: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada
Fuentes verificadas 2026-11-01
Guías prácticas
Leer en contexto
ACSM review of 137 reviews: resistance training works, and few programme details matter
The American College of Sports Medicine pooled 137 systematic reviews (over 30,000 healthy adults) and concluded that resistance training beats no exercise for strength, muscle size, power, endurance and several function tests. Few programme details changed results consistently: heavier loads (80% or more of one-repetition maximum) and 2 to 3 sets favoured strength, and at least 10 sets a week favoured muscle size, while training to failure, exercise type and periodization did not. It summarises reviews rather than new trials, gives no pooled effect sizes, and drew mostly on untrained adults and overlapping source trials.
Medicine & Science in Sports & Exercise
Nearly every resistance training plan beat no exercise; heavy loads led for strength
In a network meta-analysis of randomised trials in healthy adults (178 studies and 5097 people for strength, 119 studies and 3364 people for muscle size), nearly all resistance training prescriptions beat no exercise. Higher-load, multiset, thrice-weekly training ranked best for strength (standardised mean difference 1.60, 95% credible interval 1.38 to 1.82) and higher-load, multiset, twice-weekly training for muscle size (0.66, 0.47 to 0.85). Most prescriptions could not be statistically separated from each other (the 95% interval contained zero in 91% of the comparisons between them) and risk of bias was moderate to high, so the rankings are tentative.
British Journal of Sports Medicine
Muscle-strengthening linked to lower risk of death, heart disease, cancer and diabetes
Pooling 16 prospective cohort studies of adults, people who did muscle-strengthening activity had a 15% lower risk of all-cause mortality (RR 0.85, 95% CI 0.79 to 0.93) and a 17% lower risk of both cardiovascular disease and diabetes (RR 0.83 for each) than people who did none. The pooled mortality curve was lowest at about 40 min/week (RR 0.83), but whether larger amounts help or hurt is unclear. All of this is observational, from mostly US self-reported data, and the authors rated the certainty of evidence as very low for most outcomes.
British Journal of Sports Medicine
Protein supplements and weight training: small extra gains, smaller in older adults
Pooling 49 randomised trials with 1,863 healthy adults who did resistance training for at least 6 weeks, protein supplements added 0.30 kg of fat-free mass (95% CI 0.09 to 0.52) and 2.49 kg of one-repetition-maximum strength (0.64 to 4.33) on top of training alone. These gains were small next to the effect of training itself, were weaker with older age, and the suggested plateau near 1.6 g/kg/day was not statistically significant (p=0.079). One author has received funding from the US National Dairy Council, which supported trials in the analysis.
British Journal of Sports Medicine

